Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Daclizumab for relapsing remitting multiple sclerosis

Esta versión no es la más reciente

ver la versión actual 23 diciembre 2013

Información

DOI:
https://doi.org/10.1002/14651858.CD008127Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 octubre 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esclerosis múltiple y enfermedades raras del sistema nervioso central

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Jia Liu

    Correspondencia a: Department of Geriatric Neurology, Chinese PLA General Hospital, Beijing, China

    [email protected]

  • Luning Wang

    Department of Geriatric Neurology, Chinese PLA General Hospital, Beijing, China

  • Siyan Zhan

    Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  • Jiping Tan

    Department of Geriatric Neurology, Chinese PLA General Hospital, Beijing, China

  • Yinyin Xia

    Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

Contributions of authors

Liu J is taking the lead role in searching, identifying and assessing studies, in data extraction and analyses, and in writing up the review.

Liu J and Wang L formulated the idea for the review and developed the basis for the protocol.

Wang L gave a general advice on this protocol.

Zhan S will supervise the quality of exerting methodology.

Wang L, Tan J and will aid in identifying trials, assessing studies and in data extraction.

Xia Y will give some help in the statistics.

All authors wrote or reviewed the protocol.

Sources of support

Internal sources

  • Department of Geriatric Neurology, Chinese PLA General Hospital, China.

External sources

  • No sources of support supplied

Declarations of interest

None known.

Acknowledgements

The authors would like to acknowledge the help provided by the Cochrane Multiple Sclerosis Group.

Version history

Published

Title

Stage

Authors

Version

2013 Dec 23

Daclizumab for relapsing remitting multiple sclerosis

Review

Jia Liu, Lu‐Ning Wang, Siyan Zhan, Yinyin Xia

https://doi.org/10.1002/14651858.CD008127.pub4

2012 Apr 18

Daclizumab for relapsing remitting multiple sclerosis

Review

Jia Liu, Luning Wang, Si‐Yan Zhan, Yinyin Xia

https://doi.org/10.1002/14651858.CD008127.pub3

2010 Jun 16

Daclizumab for relapsing remitting multiple sclerosis

Review

Jia Liu, Luning Wang, Siyan Zhan, Jiping Tan, Yinyin Xia

https://doi.org/10.1002/14651858.CD008127.pub2

2009 Oct 07

Daclizumab for relapsing remitting multiple sclerosis

Protocol

Jia Liu, Luning Wang, Siyan Zhan, Jiping Tan, Yinyin Xia

https://doi.org/10.1002/14651858.CD008127

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.